COSM
Cosmos Health Inc. operates as a vertically integrated pharmaceutical company. It offers a proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, health care and baby products, medical devices, and other products through its distribution channels and an ecommerce marketplace. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece and the United Kingdom; and operates a warehousing facility. It serves wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Cosmos Health Inc. (COSM) is rated C+ (2.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Profitability (D+). The rating has held at C+ for 6 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-11 | B (3.4) | B (3.2) | D+ (1.7) | B- (3.0) | C+ (2.6) | C+ (2.8) |
| 2026-11-04 | B (3.3) | B (3.2) | D+ (1.8) | B- (2.9) | C+ (2.7) | C+ (2.8) |
| 2026-10-28 | B (3.4) | B (3.2) | D+ (1.8) | C+ (2.8) | C+ (2.7) | C+ (2.8) |
| 2026-10-21 | B (3.3) | B (3.3) | D+ (1.8) | C+ (2.7) | C+ (2.6) | C+ (2.8) |
| 2026-10-14 | B (3.3) | B (3.3) | D+ (1.8) | C (2.5) | C+ (2.6) | C+ (2.7) |